Alpa Laboratories Limited (BOM:532878)
59.00
-0.09 (-0.15%)
At close: Oct 6, 2026
Alpa Laboratories Market Cap
Alpa Laboratories has a market cap or net worth of 1.21 billion as of October 7, 2026. Its market cap has decreased by 35.15% in one year.
Market Cap
1.21B
Enterprise Value
-139.39M
Revenue
1.11B
Global Rank
n/a
Country Rank
n/a
PE Ratio
28.76
ChartMarket Cap Chart
Since August 7, 2007, Alpa Laboratories's market cap has increased from 1.15B to 1.21B, an increase of 5.31%. That is a compound annual growth rate of 0.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 1.21B | -25.72% |
| Dec 31, 2025 | 1.63B | -34.42% |
| Dec 31, 2024 | 2.49B | 14.68% |
| Dec 29, 2023 | 2.17B | 63.97% |
| Dec 30, 2022 | 1.33B | -20.65% |
| Dec 31, 2021 | 1.67B | 119.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Speciality Medicines | 1.51B |
| Lactose (India) | 1.35B |
| Parnax Lab | 1.32B |
| Godavari Drugs | 1.18B |
| Aayush Wellness | 1.13B |
| Asston Pharmaceuticals | 1.07B |
| Pharmaids Pharmaceuticals | 1.07B |
| Makers Laboratories | 1.06B |